In 2024, Paladin generated revenues of $70 million excluding products that Paladin has stopped commercializing or is in the process of discontinuing. "The reunion of Paladin and Knight ...

Knight Therapeutics Inc. GUD-T has signed a deal to buy the assets of Paladin Pharma Inc. as the Canadian drug company looks to build out its domestic business after a strategic push into South ...

Skanderborg comes into this clash with solid momentum, having won three of their last five matches. Meanwhile, Grange, playing their first T10 match, will be eager to make a strong statement. With top ...